The Effect of Botulinum Neurotoxins on the Release of Insulin from the Insulinoma Cell Lines HIT-15 and RINm5F (*)

  1. Robert S. Boyd(§),
  2. Michael J. Duggan,
  3. Clifford C. Shone and
  4. Keith A. Foster
  1. From the From Speywood Pharmaceuticals Ltd., Porton House, 1 Bath Road, Maidenhead, Berkshire SL4 4UH, United Kingdom and Division of Biologics, Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP4 OJG, United Kingdom
  1. § To whom correspondence should be addressed. Tel.: 44 628 771447; Fax: 44 628 770199.

Abstract

Western blotting of the insulin-secreting β-cell lines HIT-15 and RINm5F with anti-SNAP-25 (synaptosomal associated protein of 25 kDa), anti-synaptobrevin, and anti-syntaxin 1 antibodies revealed the presence of proteins with the same electrophoretic mobility as found in neural tissue. Permeabilization of both of these insulinoma cell lines to botulinum neurotoxin A by electroporation resulted, after 3 days of culture, in the loss of Graphic90% of SNAP-25 immunoreactivity. A similar permeabilization of these cells with botulinum neurotoxin B resulted in the cleavage of Graphic90% of the synaptobrevin-like immunoreactivities. Botulinum neurotoxin F also cleaved Graphic90% of the synaptobrevin-like immunoreactivity in RINm5F cells. The permeabilization of both insulinoma cells to neurotoxin A resulted in a >90% inhibition of potassium-stimulated, calcium-dependent insulin release. By contrast, permeabilization of the insulinoma cell lines to neurotoxin B resulted in only a Graphic60% inhibition of potassium-stimulated insulin release in HIT-15 cells, and neither neurotoxin B nor F caused inhibition in RINm5F cells. Thus HIT-15 and RINm5F cells contain the components of the putative exocytotic docking complex described in cells derived from the neural crest. In HIT-15 cells both SNAP-25 and synaptobrevin appear to be involved in calcium-dependent insulin secretion, whereas in RINm5F cells SNAP-25 but not synaptobrevin is involved.

Footnotes

  • * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    SNAP-25

    synaptosomal associated protein of 25 kDa

    BoNT

    botulinum neurotoxin

    DMEM

    Dulbecco's modified Eagle's medium

    HK-KRB

    high potassium Krebs-Ringer bicarbonate buffer

    LK-KRB

    low potassium Krebs-Ringer bicarbonate buffer

    v-SNARE and t-SNARE

    vesicle and target-soluble, respectively, N-ethylmaleimide-sensitive factor-associated protein receptor.

    • Received March 31, 1995.
    • Revision received May 26, 1995.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement